Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

176 to 200 of 658 results

Almirall to acquire US dermatology firm for $305 million upfront

Almirall to acquire US dermatology firm for $305 million upfront

17-12-2013

Spain’s largest drugmaker, Almirall says it has reached a definitive agreement to acquire Aqua Pharmaceuticals,…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

NuPathe rockets on news of takeover by Endo Health

NuPathe rockets on news of takeover by Endo Health

16-12-2013

In a third take-over deal announced this year, USA-based specialty health care company Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNeurologicalNuPathePharmaceuticalZecuity

Ampio Pharma takes spin-out route on failure to find Zertane partner

Ampio Pharma takes spin-out route on failure to find Zertane partner

16-12-2013

US drug developer Ampio Pharmaceuticals announced that it has spun off its sexual dysfunction business…

Ampio PharmaceuticalsAmpionInflammatory diseasesMen's HealthMergers & AcquisitionsPharmaceuticalProductionVyrix PharmaceuticalsZertane

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

16-12-2013

Chilean drugmaker CFR Pharmaceuticals has raised its offer price for Adcock Ingram, South Africa’s…

Adcock IngramBidvestMergers & AcquisitionsPharmaceuticalRest of the World

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

16-12-2013

Secrets of how Bristol-Myers Squibb and AstraZeneca arranged a behind-the-scenes deal to buy Amylin were…

AmylinAstraZenecaBristol-Myers SquibbDiabetesInterviewsLegalMergers & AcquisitionsPharmaceuticalUKUSA

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

GlaxoSmithKline to lift stake in Indian subsidiary to 75%

16-12-2013

UK pharma major GlaxoSmithKline said this morning that it plans to increase its stake in its publicly-listed…

Asia-PacificGlaxoSmithKlineIndiaMergers & AcquisitionsPharmaceutical

Torrent to acquire Indian branded formulations from Elder

13-12-2013

Torrent Pharmaceuticals saw its shares rise 7% to 349 rupees after it said it is acquiring the branded…

Asia-PacificElder PharmaceuticalsIndiaMergers & AcquisitionsNeurologicalPharmaceuticalTorrent PharmaceuticalsWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Emergent BioSolutions to acquire Cangene for $222 million

12-12-2013

Taking a significant step to solidify its leadership position in the growing biodefense market, US vaccine…

CangeneEmergent BioSolutionsMergers & AcquisitionsNorth AmericaPharmaceuticalVaccines

Savient to sell out to Crealta Pharma for around $120 million

12-12-2013

US drugmaker Savient Pharmaceuticals, which recently elected to file voluntary bankruptcy protection…

Anti-Arthritics/RheumaticsCrealta PharmaceuticalsKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

Report: Life science companies experience IPO slowdown

10-12-2013

Life sciences companies have been completing fewer initial public offerings (IPOs) this season as the…

Mergers & AcquisitionsPharmaceuticalRocheSalix PharmaceuticalsShireUSA

The Medicines Company acquires antibiotics maker Rempex Pharma

04-12-2013

USA-based The Medicines Company has acquired Rempex Pharmaceuticals, a company with multiple potential…

Antibiotics and Infectious diseasesMergers & AcquisitionsPharmaceuticalRempex PharmaceuticalsThe Medicines Company

Grunenthal launches public tender offer to acquire Andromaco

04-12-2013

German family-owned drugmaker Grunenthal Group has now published its public tender offer to acquire all…

ChileGrunenthalLaboratorios AndromacoMergers & AcquisitionsPharmaceuticalSouth America

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

03-12-2013

South African conglomerate Bidvest, acting on behalf of a consortium including CIH, says it has offered…

Adcock IngramBiovest InternationalCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

PharmAthene pulls out of merger deal with Theraclone

03-12-2013

USA-based biodefense company PharmAthene has decided to terminate its previously-announced all stock…

Mergers & AcquisitionsPharmaceuticalPharmAtheneTheraclone Sciences

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

02-12-2013

P Reed Maurer, long-time Japanese pharma industry watcher and president of International Alliances Limited,…

Asia-PacificMergers & AcquisitionsPharmaceutical

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

EU Commission clears acquisition of Life Technologies by Thermo Fisher, subject to conditions

26-11-2013

The European Commission has cleared under the EU Merger Regulation the proposed $13.6 billion acquisition…

EuropeLife TechnologiesMergers & AcquisitionsPharmaceuticalThermo Fisher Scientific

NicOx sets up shop in Italy with Eupharmed acquisition

26-11-2013

French biotechnology firm NicOx is planning to establish itself in Italy through a proposed acquisition…

EupharmedItalyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

Norway’s Algeta confirms takeover bid approach from Bayer

Norway’s Algeta confirms takeover bid approach from Bayer

26-11-2013

In response to recent media commentary, the board of directors of Norway’s Algeta this morning confirmed…

AlgetaBayerMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

GlaxoSmithKline cashes in $694 million of Aspen shares

GlaxoSmithKline cashes in $694 million of Aspen shares

21-11-2013

UK pharma giant GlaxoSmithKline said yesterday that it has agreed to the sale of 28.2 million ordinary…

Aspen PharmacareFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Cardiome acquires Swiss drugmaker Correvio

Cardiome acquires Swiss drugmaker Correvio

20-11-2013

Canada-based Cardiome Pharma said yesterday that it has completed the acquisition of Correvio, a privately…

BrinavessCardiome PharmaCorrevioMergers & AcquisitionsPharmaceutical

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

19-11-2013

Ireland-based drugmaker Shire’s (LSE: SHP) buy-out of US orphan drug company ViroPharma (Nasdaq: VPHM)…

CinryzeEuropeFinancialMergers & AcquisitionsPharmaceuticalShireUSAViroPharma

FTC highlights focus on health care markets competition before Judiciary subcommittee

17-11-2013

The USA’s Federal Trade Commission described its ongoing efforts to protect competition and consumers…

HealthcareLegalMergers & AcquisitionsNorth AmericaPharmaceutical

176 to 200 of 658 results

Back to top